{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:03:15Z","timestamp":1790708595433,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T00:00:00Z","timestamp":1433462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T00:00:00Z","timestamp":1433462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Gaucher disease (GD) is caused by mutations in the GBA1 gene, which encodes lysosomal \u03b2-glucocerebrosidase. Homozygosity for the L444P mutation in GBA1 is associated with high risk of neurological manifestations which are not improved by enzyme replacement therapy. Alternatively, pharmacological chaperones (PCs) capable of restoring the correct folding and trafficking of the mutant enzyme represent promising alternative therapies.Here, we report on how the L444P mutation affects mitochondrial function in primary fibroblast derived from GD patients. Mitochondrial dysfunction was associated with reduced mitochondrial membrane potential, increased reactive oxygen species (ROS), mitophagy activation and impaired autophagic flux.Both abnormalities, mitochondrial dysfunction and deficient \u03b2-glucocerebrosidase activity, were partially restored by supplementation with coenzyme Q<jats:sub>10<\/jats:sub> (CoQ) or a L-idonojirimycin derivative, N-[N\u2019-(4-adamantan-1-ylcarboxamidobutyl)thiocarbamoyl]-1,6-anhydro-L-idonojirimycin (NAdBT-AIJ) and more markedly by the combination of both treatments. These data suggest that targeting both mitochondria function by CoQ and protein misfolding by PCs can be promising therapies in neurological forms of GD.<\/jats:p>","DOI":"10.1038\/srep10903","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T10:35:59Z","timestamp":1433500559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant \u03b2-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease"],"prefix":"10.1038","volume":"5","author":[{"given":"Mario","family":"de la Mata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cot\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Oropesa-\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Garrido-Maraver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario D.","family":"Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Villanueva Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Delgado Pav\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabet","family":"Alcocer-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"de Lavera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Ybot-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Paula Zaderenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ortiz Mellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M. Garc\u00eda","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"S\u00e1nchez-Alc\u00e1zar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,5]]},"reference":[{"key":"BFsrep10903_CR1","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1083\/jcb.201208152","volume":"199","author":"FM Platt","year":"2012","unstructured":"Platt, F. M., Boland, B. & van der Spoel, A. C. The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J Cell Biol 199, 723\u2013734 (2012).","journal-title":"J Cell Biol"},{"key":"BFsrep10903_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/gte.1997.1.5","volume":"1","author":"GA Grabowski","year":"1997","unstructured":"Grabowski, G. A. Gaucher disease: gene frequencies and genotype\/phenotype correlations. Genet Test 1, 5\u201312 (1997).","journal-title":"Genet Test"},{"key":"BFsrep10903_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1055\/s-0029-1213731","volume":"29","author":"B Barton","year":"2009","unstructured":"Barton, B., Zauber, S. E. & Goetz, C. G. Movement disorders caused by medical disease. Semin Neurol 29, 97\u2013110 (2009).","journal-title":"Semin Neurol"},{"key":"BFsrep10903_CR4","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","volume":"70","author":"MA Nalls","year":"2013","unstructured":"Nalls, M. A. et al. A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol 70, 727\u2013735 (2013).","journal-title":"JAMA Neurol"},{"key":"BFsrep10903_CR5","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky, E. et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med 361, 1651\u20131661 (2009).","journal-title":"N Engl J Med"},{"key":"BFsrep10903_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.molmed.2011.05.003","volume":"17","author":"W Westbroek","year":"2011","unstructured":"Westbroek, W., Gustafson, A. M. & Sidransky, E. Exploring the link between glucocerebrosidase mutations and parkinsonism. Trends Mol Med 17, 485\u2013493 (2011).","journal-title":"Trends Mol Med"},{"key":"BFsrep10903_CR7","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1093\/hmg\/ddr610","volume":"21","author":"R de Pablo-Latorre","year":"2012","unstructured":"de Pablo-Latorre, R. et al. Impaired parkin-mediated mitochondrial targeting to autophagosomes differentially contributes to tissue pathology in lysosomal storage diseases. Hum Mol Genet 21, 1770\u20131781 (2012).","journal-title":"Hum Mol Genet"},{"key":"BFsrep10903_CR8","doi-asserted-by":"publisher","first-page":"14485","DOI":"10.1073\/pnas.0507523102","volume":"102","author":"JH Lebowitz","year":"2005","unstructured":"Lebowitz, J. H. A breach in the blood-brain barrier. Proc Natl Acad Sci U S A 102, 14485\u201314486 (2005).","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFsrep10903_CR9","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/ana.21491","volume":"64","author":"R Schiffmann","year":"2008","unstructured":"Schiffmann, R. et al. Randomized, controlled trial of miglustat in Gaucher\u2019s disease type 3. Ann Neurol 64, 514\u2013522 (2008).","journal-title":"Ann Neurol"},{"key":"BFsrep10903_CR10","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1098\/rstb.2003.1272","volume":"358","author":"A Zimran","year":"2003","unstructured":"Zimran, A. & Elstein, D. Gaucher disease and the clinical experience with substrate reduction therapy. Philos Trans R Soc Lond B Biol Sci 358, 961\u2013966 (2003).","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"BFsrep10903_CR11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1517\/13543776.2011.569162","volume":"21","author":"JM Benito","year":"2011","unstructured":"Benito, J. M., Garcia Fernandez, J. M. & Ortiz Mellet, C. Pharmacological chaperone therapy for Gaucher disease: a patent review. Expert Opin Ther Pat 21, 885\u2013903 (2011).","journal-title":"Expert Opin Ther Pat"},{"key":"BFsrep10903_CR12","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00018-005-5437-0","volume":"63","author":"AR Sawkar","year":"2006","unstructured":"Sawkar, A. R., D\u2019Haeze, W. & Kelly, J. W. Therapeutic strategies to ameliorate lysosomal storage disorders--a focus on Gaucher disease. Cell Mol Life Sci 63, 1179\u20131192 (2006).","journal-title":"Cell Mol Life Sci"},{"key":"BFsrep10903_CR13","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1742-4658.2007.05639.x","volume":"274","author":"H Yoshida","year":"2007","unstructured":"Yoshida, H. ER stress and diseases. FEBS J 274, 630\u2013658 (2007).","journal-title":"FEBS J"},{"key":"BFsrep10903_CR14","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1056\/NEJM198703053161002","volume":"316","author":"S Tsuji","year":"1987","unstructured":"Tsuji, S. et al. A mutation in the human glucocerebrosidase gene in neuronopathic Gaucher\u2019s disease. N Engl J Med 316, 570\u2013575 (1987).","journal-title":"N Engl J Med"},{"key":"BFsrep10903_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bcmd.2012.10.007","volume":"50","author":"I Bendikov-Bar","year":"2013","unstructured":"Bendikov-Bar, I., Maor, G., Filocamo, M. & Horowitz, M. Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase. Blood Cells Mol Dis 50, 141\u2013145 (2013).","journal-title":"Blood Cells Mol Dis"},{"key":"BFsrep10903_CR16","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1002\/cbic.200600217","volume":"7","author":"P Compain","year":"2006","unstructured":"Compain, P. et al. Design and synthesis of highly potent and selective pharmacological chaperones for the treatment of Gaucher\u2019s disease. Chembiochem 7, 1356\u20131359 (2006).","journal-title":"Chembiochem"},{"key":"BFsrep10903_CR17","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1021\/jm300342q","volume":"55","author":"A Trapero","year":"2012","unstructured":"Trapero, A., Gonzalez-Bulnes, P., Butters, T. D. & Llebaria, A. Potent aminocyclitol glucocerebrosidase inhibitors are subnanomolar pharmacological chaperones for treating gaucher disease. J Med Chem 55, 4479\u20134488 (2012).","journal-title":"J Med Chem"},{"key":"BFsrep10903_CR18","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1002\/cbic.200800451","volume":"9","author":"M Aguilar","year":"2008","unstructured":"Aguilar, M. et al. Molecular basis for \u03b2-glucosidase inhibition by ring-modified calystegine analogues. Chembiochem 9, 2612\u20132618 (2008).","journal-title":"Chembiochem"},{"key":"BFsrep10903_CR19","doi-asserted-by":"publisher","first-page":"7604","DOI":"10.1021\/jo015639f","volume":"66","author":"MI Garcia-Moreno","year":"2001","unstructured":"Garcia-Moreno, M. I., Benito, J. M., Ortiz Mellet, C. & Garcia Fernandez, J. M. Synthesis and evaluation of calystegine B2 analogues as glycosidase inhibitors. J Org Chem 66, 7604\u20137614 (2001).","journal-title":"J Org Chem"},{"key":"BFsrep10903_CR20","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/cbic.201200708","volume":"14","author":"P Alfonso","year":"2013","unstructured":"Alfonso, P. et al. Bicyclic derivatives of L-idonojirimycin as pharmacological chaperones for neuronopathic forms of Gaucher disease. Chembiochem 14, 943\u2013949 (2013).","journal-title":"Chembiochem"},{"key":"BFsrep10903_CR21","doi-asserted-by":"publisher","first-page":"6514","DOI":"10.1039\/c2cc32065g","volume":"48","author":"M Aguilar-Moncayo","year":"2011","unstructured":"Aguilar-Moncayo, M. et al. Tuning glycosidase inhibition through aglycone interactions: pharmacological chaperones for Fabry disease and GM1 gangliosidosis. Chem Commun (Camb) 48, 6514\u20136516 (2011).","journal-title":"Chem Commun (Camb)"},{"key":"BFsrep10903_CR22","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1039\/C3OB42530D","volume":"12","author":"J Rodriguez-Lavado","year":"2014","unstructured":"Rodriguez-Lavado, J. et al. Targeted delivery of pharmacological chaperones for Gaucher disease to macrophages by a mannosylated cyclodextrin carrier. Org Biomol Chem 12, 2289\u20132301 (2014).","journal-title":"Org Biomol Chem"},{"key":"BFsrep10903_CR23","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1055\/s-1998-1631","volume":"3","author":"JM Garc\u00eda Fern\u00e1ndez","year":"1998","unstructured":"Garc\u00eda Fern\u00e1ndez, J. M., Ortiz Mellet, C., Benito Hernandez, J. M. & Fuentes Mota, J. Synthesis of calystegine B2 analogs by tandem tautomerization-intramolecular glycosylation of thioureidosugars. Synlett 3 316\u2013318 (1998).","journal-title":"Synlett"},{"key":"BFsrep10903_CR24","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000046889","volume":"10","author":"M Ebadi","year":"2001","unstructured":"Ebadi, M. et al. Ubiquinone (coenzyme Q10) and mitochondria in oxidative stress of parkinson\u2019s disease. Biol Signals Recept 10, 224\u2013253 (2001).","journal-title":"Biol Signals Recept"},{"key":"BFsrep10903_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10545-013-9668-1","volume":"37","author":"L Matalonga","year":"2014","unstructured":"Matalonga, L. et al. Treatment effect of coenzyme Q and an antioxidant cocktail in fibroblasts of patients with Sanfilippo disease. J Inherit Metab Dis 37, 439\u2013446 (2014).","journal-title":"J Inherit Metab Dis"},{"key":"BFsrep10903_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ymgme.2007.11.018","volume":"94","author":"RH Haas","year":"2008","unstructured":"Haas, R.H. et al. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab 94, 16\u201337 (2008).","journal-title":"Mol Genet Metab"},{"key":"BFsrep10903_CR27","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0092-8674(00)80450-X","volume":"91","author":"MG Vander Heiden","year":"1997","unstructured":"Vander Heiden, M. G., Chandel, N. S., Williamson, E. K., Schumacker, P. T. & Thompson, C. B. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91, 627\u2013637 (1997).","journal-title":"Cell"},{"key":"BFsrep10903_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.tibs.2010.07.007","volume":"36","author":"R Scherz-Shouval","year":"2011","unstructured":"Scherz-Shouval, R. & Elazar, Z. Regulation of autophagy by ROS: physiology and pathology. Trends Biochem Sci 36, 30\u201338 (2011).","journal-title":"Trends Biochem Sci"},{"key":"BFsrep10903_CR29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2741\/4231","volume":"19","author":"J Garrido-Maraver","year":"2014","unstructured":"Garrido-Maraver, J. et al. Clinical applications of coenzyme Q10. Front Biosci (Landmark Ed) 19, 619\u2013633 (2014).","journal-title":"Front Biosci (Landmark Ed)"},{"key":"BFsrep10903_CR30","doi-asserted-by":"publisher","first-page":"719","DOI":"10.4161\/auto.19469","volume":"8","author":"AP Lieberman","year":"2012","unstructured":"Lieberman, A. P. et al. Autophagy in lysosomal storage disorders. Autophagy 8, 719\u2013730 (2012).","journal-title":"Autophagy"},{"key":"BFsrep10903_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.abb.2007.03.034","volume":"462","author":"I Kim","year":"2007","unstructured":"Kim, I., Rodriguez-Enriquez, S. & Lemasters, J. J. Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 462, 245\u2013253 (2007).","journal-title":"Arch Biochem Biophys"},{"key":"BFsrep10903_CR32","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.1002\/pmic.201000196","volume":"10","author":"BA Schroder","year":"2010","unstructured":"Schroder, B. A., Wrocklage, C., Hasilik, A. & Saftig, P. The proteome of lysosomes. Proteomics 10, 4053\u20134076 (2010).","journal-title":"Proteomics"},{"key":"BFsrep10903_CR33","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1046\/j.1471-4159.1996.67041677.x","volume":"67","author":"J Ezaki","year":"1996","unstructured":"Ezaki, J., Wolfe, L. S. & Kominami, E. Specific delay in the degradation of mitochondrial ATP synthase subunit c in late infantile neuronal ceroid lipofuscinosis is derived from cellular proteolytic dysfunction rather than structural alteration of subunit c. J Neurochem 67, 1677\u20131687 (1996).","journal-title":"J Neurochem"},{"key":"BFsrep10903_CR34","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1126\/science.1201940","volume":"333","author":"DR Green","year":"2011","unstructured":"Green, D. R., Galluzzi, L. & Kroemer, G. Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science 333, 1109\u20131112 (2011).","journal-title":"Science"},{"key":"BFsrep10903_CR35","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/hmg\/ddt468","volume":"23","author":"T Farfel-Becker","year":"2014","unstructured":"Farfel-Becker, T. et al. Neuronal accumulation of glucosylceramide in a mouse model of neuronopathic Gaucher disease leads to neurodegeneration. Hum Mol Genet 23, 843\u2013854 (2014).","journal-title":"Hum Mol Genet"},{"key":"BFsrep10903_CR36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1139\/o86-067","volume":"64","author":"P Strasberg","year":"1986","unstructured":"Strasberg, P. Cerebrosides and psychosine disrupt mitochondrial functions. Biochem Cell Biol 64, 485\u2013489 (1986).","journal-title":"Biochem Cell Biol"},{"key":"BFsrep10903_CR37","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cmet.2013.04.014","volume":"17","author":"LD Osellame","year":"2013","unstructured":"Osellame, L. D. et al. Mitochondria and quality control defects in a mouse model of Gaucher disease\u2013links to Parkinson\u2019s disease. Cell Metab 17, 941\u2013953 (2013).","journal-title":"Cell Metab"},{"key":"BFsrep10903_CR38","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/nchembio.1059","volume":"8","author":"RD Sentelle","year":"2012","unstructured":"Sentelle, R. D. et al. Ceramide targets autophagosomes to mitochondria and induces lethal mitophagy. Nat Chem Biol 8, 831\u2013838 (2012).","journal-title":"Nat Chem Biol"},{"key":"BFsrep10903_CR39","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ymgme.2007.11.011","volume":"93","author":"M Fuller","year":"2008","unstructured":"Fuller, M. et al. Glucosylceramide accumulation is not confined to the lysosome in fibroblasts from patients with Gaucher disease. Mol Genet Metab 93, 437\u2013443 (2008).","journal-title":"Mol Genet Metab"},{"key":"BFsrep10903_CR40","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1001\/archneurol.2009.72","volume":"66","author":"J Mitsui","year":"2009","unstructured":"Mitsui, J. et al. Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol 66, 571\u2013576 (2009).","journal-title":"Arch Neurol"},{"key":"BFsrep10903_CR41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/emmm.200900036","volume":"1","author":"G Parenti","year":"2009","unstructured":"Parenti, G. Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics. EMBO Mol Med 1, 268\u2013279 (2009).","journal-title":"EMBO Mol Med"},{"key":"BFsrep10903_CR42","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1021\/jm301557k","volume":"56","author":"RE Boyd","year":"2013","unstructured":"Boyd, R. E. et al. Pharmacological chaperones as therapeutics for lysosomal storage diseases. J Med Chem 56, 2705\u20132725 (2013).","journal-title":"J Med Chem"},{"key":"BFsrep10903_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1055\/s-2004-815830","volume":"35","author":"R Artuch","year":"2004","unstructured":"Artuch, R. et al. Cerebrospinal fluid concentrations of idebenone in Friedreich ataxia patients. Neuropediatrics 35, 95\u201398 (2004).","journal-title":"Neuropediatrics"},{"key":"BFsrep10903_CR44","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1083\/jcb.152.4.657","volume":"152","author":"N Mizushima","year":"2001","unstructured":"Mizushima, N. et al. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol 152, 657\u2013668 (2001).","journal-title":"J Cell Biol"},{"key":"BFsrep10903_CR45","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1039\/c1ob05234a","volume":"9","author":"M Aguilar-Moncayo","year":"2011","unstructured":"Aguilar-Moncayo, M. et al. Bicyclic (galacto)nojirimycin analogues as glycosidase inhibitors: effect of structural modifications in their pharmacological chaperone potential towards \u03b2-glucocerebrosidase. Org Biomol Chem 9, 3698\u20133713 (2011).","journal-title":"Org Biomol Chem"},{"key":"BFsrep10903_CR46","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0009-8981(94)90055-8","volume":"228","author":"P Rustin","year":"1994","unstructured":"Rustin, P. et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 228, 35\u201351 (1994).","journal-title":"Clin Chim Acta"},{"key":"BFsrep10903_CR47","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265\u2013275 (1951).","journal-title":"J Biol Chem"},{"key":"BFsrep10903_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4161\/auto.5.1.7174","volume":"5","author":"A Rodriguez-Hernandez","year":"2009","unstructured":"Rodriguez-Hernandez, A. et al. Coenzyme Q deficiency triggers mitochondria degradation by mitophagy. Autophagy 5, 19\u201332 (2009).","journal-title":"Autophagy"},{"key":"BFsrep10903_CR49","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1096\/fj.10-165340","volume":"25","author":"D Cotan","year":"2011","unstructured":"Cotan, D. et al. Secondary coenzyme Q10 deficiency triggers mitochondria degradation by mitophagy in MELAS fibroblasts. FASEB J 25, 2669\u20132687 (2011).","journal-title":"FASEB J"},{"key":"BFsrep10903_CR50","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/glycob\/10.6.629","volume":"10","author":"L Brade","year":"2000","unstructured":"Brade, L., Vielhaber, G., Heinz, E. & Brade, H. In vitro characterization of anti-glucosylceramide rabbit antisera. Glycobiology 10, 629\u2013636 (2000).","journal-title":"Glycobiology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep10903","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep10903.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep10903.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T23:15:43Z","timestamp":1672960543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep10903"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,5]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,9,1]]}},"alternative-id":["BFsrep10903"],"URL":"https:\/\/doi.org\/10.1038\/srep10903","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,5]]},"assertion":[{"value":"20 January 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10903"}}